ZP SPV 3 K/S: Financial statements 2021
CVR: 41038039
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ZP SPV 3 K/S (CVR 41038039) has filed annual accounts for 2021. In 2021, the company reported revenue of USD 1,610,000 and a net result of USD 50,000 compared with USD -118 the year before. That is an increase of 123,746.2% compared with the year before. The profit margin was 3.1%. Equity in the 2021 report amounted to USD 5,634,000. The solvency ratio was 81.3%.
- Revenue
- USD 1,610,000
- Gross Profit
- USD 1,610,000
- Profit/Loss
- USD 50,000
- Equity
- USD 5,634,000
- Total Assets
- USD 6,934,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 1.6M USD | 1.6M USD | 50K USD | 5.6M USD | - |
| 2020 | 1K USD | 1K USD | -118 USD | 6K USD | - |
Official annual report
Find more companies like ZP SPV 3 K/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
ZP SPV 3 K/S has published its annual report for 2020. Revenue came to DKK 1,300, and the net result was DKK -118.
As of June 30, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZP SPV 3 K/S.
As of June 30, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZP SPV 3 K/S.
About ZP SPV 3 K/S
ZP SPV 3 K/S is a Danish company of the type Kommanditselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of ZP General Partner 3 ApS. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,039,000 compared with DKK -34,739,000 the year before. Equity in the 2025 report amounted to DKK 429,000.
